Supernus Pharmaceuticals Inc (LTS:0LB2)
$ 28.7 0 (0%) Market Cap: 1.58 Bil Enterprise Value: 1.32 Bil PE Ratio: 0 PB Ratio: 1.71 GF Score: 76/100

Supernus Pharmaceuticals Inc (LTS:0LB2) Transcripts

  • 1